Greater Bay Area Initiative - Viablity & Investor Implications, Part II
Last week in Part I we discussed what the GBA Initiative is. The importance of the GBA Initiative cannot be overstated. It is critical to the...
584 Views
Alphamab IPO: Interims from Merck's Breast Cancer Trial Bodes Well for Alphamab and Junshi
Last night, Merck & Co Inc. (MRK US) announced that its Keytruda hits primary endpoint in Phase III (KEYNOTE-522) clinical trial in the...
638 Views
šØš³šš° That Was The Week That Was ā¢ China/Hong Kong 22nd-27th July 2019 @Smartkarma
TW3 CHINA/HONG KONG 22-27 JUNEThis TW3 covers China and Hong Kong and is a companion to the North Asian TW3 published earlier today.Ā The weight of...
722 Views
Greater Bay Initiative - Upping Integration, Part 1
The US-China trade tensions have eased for the moment. But Chinaās leaders realise that the real war between a rising and an existing economic...
553 Views
Alphamab (åŗ·å®ę°ē) IPO: Strong R&D Capability and Innovative Platforms
Alphamab, a China-based biotech company, is seeking to raise USD 200 to 300 million via a listing on the Hong Kong Stock Exchange.Ā In this...
753 Views